Product image of Glucose Aguettant (Glucose) supplied by GNH India

Glucose Aguettant

Active Ingredient:
Glucose
Origin:
EU

Glucose Aguettant (Glucose)

Glucose Aguettant is an intravenous solution that contains glucose as its sole active ingredient. The product is supplied in a standard, unspecified strength and is intended for parenteral administration. Classified as an excipient/solvent, it functions as a nutrient and energy source for cellular metabolism. Glucose Aguettant is marketed in the European Union and is available only by prescription for use under medical supervision in hospitals and other clinical settings.

Manufacturer / TM Owner

Laboratoire Aguettant

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucose Aguettant is used in clinical practice to address conditions where rapid glucose and fluid replacement are required.

  • Treatment of hypoglycemia when oral intake is not feasible.
  • Fluid and electrolyte replacement in patients undergoing dehydration.
  • Nutritional support during peri‑operative care or in critically ill patients.
  • Adjunct to parenteral nutrition regimens to maintain blood glucose levels.
  • Support for patients receiving insulin therapy who are at risk of low blood glucose.

Side Effects

When administered intravenously, Glucose Aguettant may be associated with a range of observed effects, most of which are related to its glucose content and infusion characteristics.

Common

  • Transient hyperglycemia.
  • Local irritation or phlebitis at the infusion site.
  • Mild nausea or headache.

Serious

  • Severe hyperglycemia requiring medical intervention.
  • Anaphylactic or severe allergic reaction.
  • Significant electrolyte disturbances (e.g., severe hypokalemia).
  • Volume overload leading to pulmonary edema.
  • Hyperosmolar state with neurologic symptoms.

Precautions & Warnings

Healthcare providers should consider several precautions before prescribing Glucose Aguettant to ensure patient safety.

  • Assess baseline blood glucose and adjust infusion rate accordingly.
  • Monitor electrolytes, especially potassium and sodium, during therapy.
  • Use caution in patients with renal or cardiac failure due to risk of fluid overload.
  • Avoid rapid infusion in neonates and infants.
  • Review contraindications such as known hypersensitivity to glucose solutions.
  • Ensure proper aseptic technique to prevent catheter‑related infection.

Avoid Interactions

Glucose Aguettant can interact with other medications or clinical conditions, influencing its safety or efficacy.

Avoid

  • Concurrent high‑dose insulin therapy without glucose monitoring.
  • Co‑administration with drugs that cause severe hypokalemia (e.g., high‑dose diuretics).
  • Use with hyperosmolar agents that may exacerbate hyperglycemia.

Use with caution

  • Beta‑blockers that mask hypoglycemia symptoms.
  • Corticosteroids that increase blood glucose levels.
  • Parenteral nutrition solutions containing dextrose to avoid excessive glucose load.

Frequently Asked Questions

Glucose Aguettant is an intravenous solution that contains glucose as its active ingredient. It is administered directly into a vein by a healthcare professional.

It is commonly prescribed for hypoglycemia, fluid and electrolyte replacement, and as part of nutritional support during peri‑operative care or in critically ill patients.

The solution provides a rapid source of glucose that can raise blood sugar levels when oral intake is not possible or when immediate correction is needed.

Blood glucose, electrolyte levels (especially potassium and sodium), and fluid balance should be regularly monitored while the infusion is ongoing.

Use in neonates and infants requires special caution and typically a slower infusion rate; pediatric use should follow institutional protocols.

Common side effects include transient hyperglycemia, mild nausea, headache, and local irritation or phlebitis at the infusion site.

Avoid in patients with known hypersensitivity to glucose solutions, severe renal or cardiac failure without close monitoring, and when combined with high‑dose insulin without glucose checks.

Concurrent insulin may increase the risk of hypoglycemia; dosage adjustments and frequent glucose monitoring are necessary when both are used.

Renal impairment can affect fluid and electrolyte balance, so infusion rates and total volume should be individualized and closely monitored.

It can be co‑administered with many IV fluids, but compatibility should be confirmed, especially when mixed with hyperosmolar or high‑dextrose solutions.

Dosage is individualized based on the patient’s blood glucose level, clinical condition, and overall fluid requirements; it must be prescribed by a qualified clinician.

The infusion should be stopped immediately, and appropriate emergency measures, such as administration of antihistamines or epinephrine, should be taken according to clinical guidelines.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.